Notable Analyst Rating Changes 05/10: (TPX) (PRU) (KERX) Upgraded; (VRTX) (HGSI) (ORCL) Downgraded
Tweet Send to a Friend
Get Alerts TPX Hot Sheet
Trade TPX Now!
UPGRADES
Raymond James upgrades Tempur-Pedic (NYSE: TPX) from Market Perform to Strong Buy.
Prudential Financial (NYSE: PRU) boosted by two:
Keryx Biopharmaceuticals (Nasdaq: KERX) upgraded at two firms:
DOWNGRADES
RBC Capital moves Vertex (Nasdaq: VRTX) from Top Pick to Outperform, its price target raised from $63 to $69.
Leerink Swann cuts Human Genome Sciences (Nasdaq: HGSI) from Outperform to Market Perform, lowering its price target from $22 to $16.
ThinkEquity chops Oracle (Nasdaq: ORCL) from Buy to Hold.
Macquarie downgrades Aon Corp (NYSE: AON) from Outperform to Neutral.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
Benchmark begins Smith & Wesson Holding (Nasdaq: SWHC) with a Buy and $9 price target. Click Here for more color.
Stifel Nicolaus initiates Cree (Nasdaq: CREE) with a Buy and $38 price target.
Goldman Sachs assumes Phillips 66 (NYSE: PSX) at Neutral and $39 target.
Société Générale begins Sanofi (NYSE: SNY) with a Buy rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Raymond James upgrades Tempur-Pedic (NYSE: TPX) from Market Perform to Strong Buy.
Prudential Financial (NYSE: PRU) boosted by two:
- Evercore Partners from Equalweight to Overweight, price target lowered from $71 to $65; and
- Morgan Stanley from Equal Weight to Overweight with a price target of $66.
Keryx Biopharmaceuticals (Nasdaq: KERX) upgraded at two firms:
- Ladenburg Thalmann from Neutral to Buy, new price target of $3; and
- Roth Capital from Neutral to Buy, price target raised from $4 to $7.
DOWNGRADES
RBC Capital moves Vertex (Nasdaq: VRTX) from Top Pick to Outperform, its price target raised from $63 to $69.
Leerink Swann cuts Human Genome Sciences (Nasdaq: HGSI) from Outperform to Market Perform, lowering its price target from $22 to $16.
ThinkEquity chops Oracle (Nasdaq: ORCL) from Buy to Hold.
Macquarie downgrades Aon Corp (NYSE: AON) from Outperform to Neutral.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
Benchmark begins Smith & Wesson Holding (Nasdaq: SWHC) with a Buy and $9 price target. Click Here for more color.
Stifel Nicolaus initiates Cree (Nasdaq: CREE) with a Buy and $38 price target.
Goldman Sachs assumes Phillips 66 (NYSE: PSX) at Neutral and $39 target.
Société Générale begins Sanofi (NYSE: SNY) with a Buy rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Notable Analyst Rating Changes 05/22: (BMY) (CREE) (TEX) Upgraded; (IGTE) (CCL) (NCT) Downgraded
- Trading Radar for 05/22: Salesforce.com (CRM), GameStop (GME), Heinz (HNZ), Gap (GPS),
- Market Wrap: Sprint Ponies Up for Clearwire; Herbalife Engages Auditor; 'One' for Microsoft
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Stifel Nicolaus, Raymond James, Morgan Stanley, Merrill Lynch, Bank of America, ThinkEquity, Roth Capital, RBC Capital, Ladenburg Thalmann Financial Services, Notable Analyst Rating Changes
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
